The 3xTg-AD transgenic mouse model of Alzheimer’s disease (AD) is an important tool to investigate the relationship between development of pathological amyloid-β (Aβ) and tau, neuroinflammation, and cognitive impairments. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.